Assist analysis of user-selected discrete thyroid nodules larger than 1 cm on ultrasound when a biopsy recommendation is required, after the physician's initial image review.
Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Assist analysis of user-selected discrete thyroid nodules larger than 1 cm on ultrasound when a biopsy recommendation is required, after the physician's initial image review.
FDA source Exact FDA submission Checked 2026-09-08
Post-acquisition, clinician-reviewed CADe analysis with ROI contouring, quantification, visualization, and report generation after initial physician review
FDA source Exact FDA submission Checked 2026-09-08
Ultrasound images from FDA-cleared ultrasound systems; user-selected discrete thyroid nodules larger than 1 cm. The FDA comparison matrix lists DICOM 3.0, Bitmap, and JPEG image formats.
FDA source Exact FDA submission Checked 2026-09-08
User-defined or AI-suggested ROI contour; annotations and quantified/visualized hyperechoic foci, echogenicity, texture, margin, orientation, and anechoic areas; a report based on user-entered and annotated findings that can be printed or saved as PDF.
FDA source Exact FDA submission Checked 2026-09-08
Scope is limited to discrete thyroid nodules larger than 1 cm for which a biopsy recommendation is required and follows initial physician review. The packet describes an assistive tool and does not provide numeric clinical performance results.
FDA source Exact FDA submission Checked 2026-09-08
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K203555
FDA source Exact FDA submission Checked 2026-08-31
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
Windows-based standalone PC or review station with local report storage, PDF output, or printing. FDA materials identify DICOM 3.0, Bitmap, and JPEG inputs but do not establish PACS, RIS, EHR, or cloud integration.
FDA source Exact FDA submission Checked 2026-09-08
Public source Exact FDA submission Checked 2026-08-13
Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
The FDA 510(k) summary reports standalone performance studies of AI-suggested contours for user-selected nodules on images from FDA-cleared ultrasound systems and states that the contours were effective. No sample size or numeric result is provided; no applicable FDA performance standard is identified.
FDA source Exact FDA submission Checked 2026-09-08
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
AmCAD-UT regulatory performance study summary
Stand-Alone Performance · Population described in the exact-submission ACR model card
exact submission · Tested version: Exact product version not reported; regulatory study summarized for FDA submission K203555 · Independence not established
K203555
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08
No public price or quote for the exact K203555 configuration was established in this review.
Reimbursement and coding
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-08
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K203555. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Public source Exact FDA submission Checked 2026-09-08
Verify security and privacy controls: Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Verify training: Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Verify pricing and total cost: No public price or quote for the exact K203555 configuration was established in this review.
Verify reimbursement and coding relevance: No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Verify local validation and lifecycle monitoring: Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-08Last searched
21Fields reviewed
9Source classes checked
11Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads
Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA scope controls clinical claims. ACR provides bounded exact-submission catalog context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 11 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric,...
Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during...